As of June 13, 2025, Penumbra Inc (PEN) reports a Gross Margin of 63.20%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Penumbra Inc's Gross Margin
Over recent years, Penumbra Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 63.20% |
| 2023-12-31 | 64.49% |
| 2022-12-31 | 63.18% |
| 2021-12-31 | 63.59% |
| 2020-12-31 | 60.35% |
This slight upward trend highlights how Penumbra Inc manages its operational efficiency and pricing power over time.
Comparing Penumbra Inc's Gross Margin to Peers
To better understand Penumbra Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Penumbra Inc (PEN) | 63.20% |
| Inari Medical Inc (NARI) | 88.03% |
| Shockwave Medical Inc (SWAV) | 86.94% |
| ABIOMED Inc (ABMD) | 81.76% |
| Inmode Ltd (INMD) | 80.31% |
| Novocure Ltd (NVCR) | 77.34% |
Compared to its competitors, Penumbra Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.